Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
New Strong Sell Stocks for September 23rd
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
American Campus Communities, Inc. is the owner, manager and developer of student housing communities in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 0.5% downward over the last 30 days.
Intellicheck, Inc. (IDN - Free Report) is a developer and marketer of threat identification and identity authentication solutions for retail fraud prevention, law enforcement threat identification, and mobile and handheld access control and security systems. The Zacks Consensus Estimate for its current year earnings has been revised more than 100% downward over the last 30 days.
Retail Properties of America, Inc. is the owner and operator of high quality, strategically located open-air shopping centers. The Zacks Consensus Estimate for its current year earnings has been revised 4.4% downward over the last 30 days.
Stitch Fix, Inc. (SFIX - Free Report) is a seller of a variety of apparel, shoes, and accessories through its website as well as mobile app. The Zacks Consensus Estimate for its current year earnings has been revised 5.1% downward over the last 30 days.
IsoRay, Inc. is a developer and manufacturer of isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Zacks Consensus Estimate for its current year earnings has been revised 50% downward over the last 30 days.
View the entire Zacks Rank #5 List.